Table 2—

Matrix of Pearson’s correlation coefficients among changes in metabolic cardiovascular syndrome components stratified by sex

ChangesBMIWHRDiastolic blood pressureSystolic blood pressureFasting insulinFasting glucoseGlucose 120 minHDL cholesterolTriglycerides
Ely study population:
 BMI0.340.170.110.280.180.24−0.280.22
 WHR0.210.110.070.100.040.08−0.11*0.02
 Diastolic blood pressure0.180.11*0.790.040.010.07−0.070.12*
 Systolic blood pressure0.190.080.780.04−0.02−0.04−0.100.10
 Fasting insulin0.230.130.080.070.240.13*−0.10*0.15
 Fasting glucose0.210.010.070.050.120.560.080.25
 Glucose 120 min0.21−0.020.01−0.020.090.33−0.11*0.26
 HDL cholesterol−0.09−0.01−0.03−0.05−0.060.01−0.09*−0.26
 Triglycerides0.250.050.050.060.16*0.140.19−0.09*
Individuals not being treated with antihypertensive or lipid-lowering drugs:
 BMI0.370.320.220.270.210.28−0.320.30
 WHR0.250.180.110.17*0.220.11−0.15*0.14*
 Diastolic blood pressure0.150.060.790.15*0.070.09−0.100.10
 Systolic blood pressure0.160.000.750.050.00−0.06−0.070.10
 Fasting insulin0.190.12*0.050.060.260.11−0.070.18
 Fasting glucose0.210.030.08−0.030.10*0.42−0.000.02
 Glucose 120 min0.220.11*0.070.010.160.27−0.13*0.11
 HDL cholesterol−0.07−0.03−0.10*−0.14*−0.11*0.04−0.14*−0.19
 Triglycerides0.290.090.060.090.070.10*0.16−0.11*
  • Data are Pearson’s correlation coefficients. Coefficients for men are in bold; those for women are not in bold.

  • *

    * P < 0.05,

  • P < 0.01,

  • P < 0.001.